Anika Therapeutics Inc Cash Flow Reinvestment Rate
Anika Therapeutics Inc cash flow reinvestment rate. Anika Therapeutics Inc (ANIK) has a Cash Flow Reinvestment Rate of 0.14x as of December 2025, reinvesting $648.00K (capex $648.00K ) from operating cash flow of $4.64 Million. Explore ANIK operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Anika Therapeutics Inc (1997–2025)
Cash flow reinvestment rate of Anika Therapeutics Inc from 1997 to 2025. Historical reinvestment intensity for Anika Therapeutics Inc across 26 annual periods. Explore Anika Therapeutics Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Anika Therapeutics Inc Cash Flow Reinvestment Rate by Year (1997–2025)
Anika Therapeutics Inc cash flow reinvestment rate by year from 1997 to 2025. Year-by-year capital reinvestment analysis for Anika Therapeutics Inc. For the full cash flow conversion analysis, see how efficiently does Anika Therapeutics Inc generate cash.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.61x | $6.83 Million | $11.19 Million | $6.83 Million | ▼ -79.5% |
| 2024 | 2.97x | $16.07 Million | $5.40 Million | $7.73 Million | ▼ -12.4% |
| 2022 | 3.40x | $14.97 Million | $4.41 Million | $7.49 Million | ▲ +273.0% |
| 2021 | 0.91x | $7.64 Million | $8.40 Million | $5.14 Million | ▼ -55.3% |
| 2020 | 2.04x | $26.59 Million | $13.06 Million | $1.63 Million | ▲ +66.1% |
| 2019 | 1.23x | $45.34 Million | $37.01 Million | $2.83 Million | ▼ -14.9% |
| 2018 | 1.44x | $50.26 Million | $34.92 Million | $4.66 Million | ▲ +370.7% |
| 2017 | 0.31x | $12.48 Million | $40.81 Million | $8.98 Million | ▼ -65.8% |
| 2016 | 0.89x | $21.27 Million | $23.80 Million | $14.01 Million | ▲ +15.5% |
| 2015 | 0.77x | $30.23 Million | $39.06 Million | $9.22 Million | ▲ +272.6% |
| 2014 | 0.21x | $8.30 Million | $39.98 Million | $1.55 Million | ▲ +1085.4% |
| 2013 | 0.02x | $440.89K | $25.16 Million | $440.89K | ▼ -87.7% |
| 2012 | 0.14x | $1.50 Million | $10.55 Million | $1.50 Million | ▲ +3.6% |
| 2011 | 0.14x | $1.40 Million | $10.17 Million | $1.40 Million | ▼ -61.2% |
| 2010 | 0.35x | $2.78 Million | $7.85 Million | $2.78 Million | ▼ -72.3% |
| 2009 | 1.28x | $3.96 Million | $3.09 Million | $3.96 Million | ▼ -73.1% |
| 2008 | 4.77x | $16.25 Million | $3.41 Million | $16.25 Million | ▲ +45.2% |
| 2007 | 3.28x | $14.76 Million | $4.49 Million | $14.76 Million | ▲ +403.3% |
| 2006 | 0.65x | $1.31 Million | $2.00 Million | $1.31 Million | ▲ +163.1% |
| 2005 | 0.25x | $1.60 Million | $6.45 Million | $1.60 Million | ▲ +1146.4% |
| 2004 | 0.02x | $474.00K | $23.82 Million | $474.00K | ▼ -84.4% |
| 2003 | 0.13x | $256.00K | $2.01 Million | $256.00K | ▼ -52.5% |
| 2002 | 0.27x | $88.91K | $332.03K | $88.91K | ▼ -87.4% |
| 1999 | 2.13x | $1.70 Million | $800.00K | $1.70 Million | ▲ +228.4% |
| 1998 | 0.65x | $2.20 Million | $3.40 Million | $2.20 Million | ▲ +460.8% |
| 1997 | 0.12x | $300.00K | $2.60 Million | $300.00K | — |